Skip to content

Remedium Capital Partners, LLC

Follow

13F filer, CIK 2104501, WEST PALM BEACH, FL

Remedium Capital Partners, LLC reported $273,591,243 across 6 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-13.

Accepted , ingested 13F-HR 0002104501-26-000021

Period
2026-09-30
Reported value
$274M
Holdings
6
Top 10 weight
100%
New
2
Sold out
2

Largest buys vs the previous quarter

SecurityShares changeApprox. value
DMRAnew+2,045,473$43.5M
KRSAnew+518,500$16.6M
JBIOadded+230,064$3.23M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
APGEexited-586,691-$77.9M
DMRAexited-2,045,473-$53.2M
ORKAreduced-611,511-$50.9M
SYREreduced-303,549-$27M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0002104501-26-000021, largest first. % of portfolio is the value over $273,591,243, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
SYRESPYRE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 1,456,231 shares; 2026Q1: 1,456,231 shares; 2026Q2: 1,464,169 shares; 2026Q3: 1,160,620 shares 1,160,620$103M37.77%-303,549Timeline
ORKAORUKA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 1,552,414 shares; 2026Q1: 1,565,661 shares; 2026Q2: 1,565,661 shares; 2026Q3: 954,150 shares 954,150$79.5M29.05%-611,511Timeline
DMRADAMORA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 2,045,473 shares 2,045,473$43.5M15.91%newTimeline
JBIOJADE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 1,577,750 shares; 2026Q1: 1,577,750 shares; 2026Q2: 1,577,750 shares; 2026Q3: 1,807,814 shares 1,807,814$25.4M9.28%+230,064Timeline
KRSAKORSANA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 518,500 shares 518,500$16.6M6.06%newTimeline
CBIOCRESCENT BIOPHARMA INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 361,250 shares; 2026Q3: 361,250 shares 361,250$5.27M1.93%0Timeline

Sold out in Q3 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
APGEAPOGEE THERAPEUTICS INC586,691$77.9Mshares
DMRADAMORA THERAPEUTICS INC2,045,473$53.2Mshares

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0002104501-26-000021 base2026-11-13